Published in Prostaglandins on May 01, 1986
The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med (1996) 2.11
Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest (1990) 1.49
Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol (1990) 1.10
Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child (1995) 1.01
Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol (1992) 0.87
Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulation. J Clin Invest (1989) 0.80
LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin. Arch Dermatol Res (1996) 0.75
Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes. Clin Exp Immunol (1987) 0.75
Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva. Am J Pathol (1988) 0.75
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res (2010) 1.60
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
Human mast cells produce IL-8. J Immunol (1993) 1.44
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme. Blood (1998) 1.12
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol (1998) 1.06
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes. J Invest Dermatol (1997) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
The bulge is the source of cellular renewal in the sebaceous gland of mouse skin. Arch Dermatol Res (2000) 0.98
Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial. J Eur Acad Dermatol Venereol (2013) 0.97
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc Natl Acad Sci U S A (1995) 0.94
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res (2007) 0.94
Biological and chemical characterization of eosinophil chemotactic factors from human leukocytes. Agents Actions Suppl (1983) 0.93
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92
Chemotactic leukotrienes in psoriasis. Lancet (1982) 0.92
Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol (1996) 0.92
Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol (1981) 0.91
Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol (1994) 0.91
Ultrastructure of inclusions in peripheral blood mononuclear cells in sarcoidosis. Am J Pathol (1975) 0.91
P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol (1995) 0.91
Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res (1995) 0.91
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J Am Acad Dermatol (1991) 0.90
In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids (1981) 0.90
Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol (1986) 0.90
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol (1996) 0.90
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res (2012) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Mast cells as modulators of hair follicle cycling. Exp Dermatol (1995) 0.89
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol (1995) 0.89
Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun (1995) 0.88
Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis. Br J Dermatol (1988) 0.88
Detection of human papillomaviruses in paraffin-embedded condylomata acuminata--comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J Invest Dermatol (1991) 0.88
Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology (1994) 0.87
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
Primary leiomyosarcoma of the skin. A histological and immunohistochemical analysis. Acta Derm Venereol (1993) 0.86
Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Br J Dermatol (1984) 0.86
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol (1996) 0.86
In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86
Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol (1995) 0.86
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica (1988) 0.85
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol (1985) 0.85
Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci (1994) 0.85
Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol (1994) 0.85
Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol (1994) 0.85
Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol (1995) 0.85
Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose. J Invest Dermatol (1982) 0.84
Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.84
Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol (1984) 0.84
Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.83
[Annular elastolytic giant cell granuloma with a spontaneous healing tendency]. Hautarzt (1995) 0.83
AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochem Biophys Res Commun (1996) 0.83
Amelanotic malignant melanoma presenting as malignant schwannoma. Br J Dermatol (1993) 0.83
Immunoreactive leukotrienes in nettle plants (Urtica urens). Int Arch Allergy Appl Immunol (1990) 0.83
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer (1994) 0.83
Expression of growth factor receptors on human melanoma cells: comparison of modulating effects of interferons and retinoids. Exp Dermatol (1993) 0.82
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol (1979) 0.82
Mast cells in melanocytic tumours. Arch Dermatol Res (1995) 0.82
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica (1983) 0.82
In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes. Scand J Immunol (1981) 0.82
The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem Biophys Res Commun (1995) 0.82
Induction of apoptosis in human HaCaT keratinocytes. Arch Dermatol Res (1996) 0.81
Neutrophil-derived eosinophil chemotactic factor production induced by immune complexes. Int Arch Allergy Appl Immunol (1981) 0.81
Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy (1996) 0.81
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J Invest Dermatol (1997) 0.81
Modulation of eosinophil chemotaxis and eosinophil chemotactic factor release by concanavalin A. Int Arch Allergy Appl Immunol (1978) 0.81
Ketotifen in cholinergic urticaria. J Allergy Clin Immunol (1990) 0.81
Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol (1995) 0.81